The spectrum of nonmotor symptoms in early Parkinson disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neurology

• Publication date

  2013-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.0b013e31827deb74PMID 23319473PMCID PMC3589180
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Motor and non-motor predictors of illness-related distress in Parkinson's disease.

  2012cited by this paper
• Parkinson's disease motor subtypes and mood

  2012cited by this paper
• Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease

  2012cited by this paper
• Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: A prospective study

  2012cited by this paper
• Validation of the non-motor symptoms questionnaire (NMS-Quest).

  2012cited by this paper
• The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease

  2011cited by this paper
• Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: Frequent but mild

  2011influential reference
• Cognitive impairment in nondemented Parkinson's disease

  2011cited by this paper
• The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire

  2010cited by this paper
• Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease

  2010cited by this paper
• Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

  2010cited by this paper
• The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease

  2009cited by this paper
• The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson’s disease

  2009cited by this paper
• Cognitive impairment in incident, untreated Parkinson disease

  2009cited by this paper
• The retina in Parkinson's disease.

  2009cited by this paper
• REM sleep behaviour disorder in Parkinson’s disease is associated with specific motor features

  2008cited by this paper
• Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study

  2008cited by this paper
• Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

  2008influential reference
• Defining mild cognitive impairment in Parkinson's disease

  2007cited by this paper
• Lewy body dysphagia

  2007cited by this paper
• Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients

  2007cited by this paper
• Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies

  2006cited by this paper
• International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study

  2006influential reference
• Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases.

  2006cited by this paper
• Cognitive profile of patients with newly diagnosed Parkinson disease

  2005cited by this paper
• The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment

  2005cited by this paper
• SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

  2003cited by this paper
• How widespread are the symptoms of an overactive bladder and how are they managed? A population‐based prevalence study

  2001cited by this paper
• What contributes to quality of life in patients with Parkinson's disease?

  2000cited by this paper
• Lewy body dysphagia.

  1995cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992influential reference
• Variable expression of Parkinson's disease

  1990influential reference
• Development and validation of a geriatric depression screening scale: a preliminary report.

  1982influential reference
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Parkinsonism

  1967cited by this paper

• Stage-specific interactions among PLM, RBD, and OSAHS in parkinson’s disease and MSA

  2026cites this paper
• Extracellular Vesicles in Neuroinflammation: Insights into Pathogenesis, Biomarker Potential, and Therapeutic Strategies

  2026cites this paper
• Neurodegeneration as Ecosystem Failure: A New Paradigm for Prevention and Treatment

  2025cites this paper
• Sequence Symmetry Analysis of the Interrelationships Between Ramelteon and Parkinson's Disease

  2025cites this paper
• Effects of two types of repetitive transcranial magnetic stimulation on brain network in Parkinson’s disease

  2025cites this paper
• Evaluation of Free-Living Motor Symptoms in Patients With Parkinson Disease Through Smartwatches: Protocol for Defining Digital Biomarkers

  2025cites this paper
• Correlation between plasma epidermal growth factor and follow-up cognitive decline in Parkinson’s disease

  2025cites this paper
• Oral Health and Dental Health Care Experiences of Patients From the Netherlands With Parkinson's Disease: A Qualitative Study

  2025cites this paper
• Biomarker Detection and Therapy of Parkinson's and Alzheimer's disease using upconversion based approach: A Comprehensive Review.

  2025cites this paper
• Upper Limb Exercises Reduce Non-motor Symptoms and Increase Cognitive Function in Parkinson's Disease: Randomized Controlled Trial.

  2025cites this paper
• Crossing Barriers: Advancements in Macromolecular Therapeutics for Neurodegenerative Diseases and Strategies to Overcome the Blood-Brain Barrier.

  2025cites this paper
• Respiratory Muscle Strength Training in Parkinson’s Disease—A Systematic Review and Meta-Analysis

  2025cites this paper
• Trends, Prevalence of Bradyarrhythmia and Pacemaker Implantation in Patients with Parkinson’s Disease

  2025cites this paper
• The role of mitochondrial genetics in Parkinson's disease: Long-read sequencing as an emerging method.

  2025cites this paper
• Epidemiology of autonomic dysfunction in Parkinson's disease (Review)

  2025cites this paper
• Prevalence, contributing factors, and clinical impact of apathy in Parkinson's disease.

  2025cites this paper
• Brain structural MRI marker for predicting conversion to Parkinson’s disease in individuals with prodromal symptoms

  2025cites this paper
• Investigation of nonmotor symptoms and their clinical correlates in patients with Parkinson's disease.

  2025cites this paper
• Videonystagmography features and clinical symptoms correlate with Parkinson's clinical subtypes

  2025cites this paper
• Parkinson Disease Signaling Pathways, Molecular Mechanisms, and Potential Therapeutic Strategies: A Comprehensive Review

  2025cites this paper
• Dysphagia in Parkinson´s disease. A 5-year follow-up study

  2025cites this paper
• A deep learning approach for classification of Parkinson’s disease using single photon emission computerized tomography

  2025cites this paper
• Relationship Between Melatonin Receptor Agonists and Parkinson's Disease

  2024cites this paper
• Parkinson's disease subtypes: Approaches and clinical implications.

  2024cites this paper
• Exploring the lived experiences of individuals with Parkinson’s disease and their relatives: insights into care provision experiences, disease management support, self-management strategies, and future needs in Germany (qualitative study)

  2024cites this paper
• Orofacial pain and dysfunction in patients with special needs, with a focus on interdisciplinarity.

  2024cites this paper
• Non-Motor Symptom Management: Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients

  2024cites this paper
• The Effects of Whole-Body Exercise on Swallowing Function in Older Adults With Parkinson's Disease: A Proof-of-Principle Study.

  2024cites this paper
• Prevalence and clinical correlates of nonmotor symptoms in Parkinson’s disease in a tertiary health-care center in Turkey

  2024cites this paper
• Burden of non-motor symptoms of Parkinson’s disease: cost-of-illness and quality-of-life estimates through a scoping review

  2024cites this paper
• New Insights into Mitochondria in Health and Diseases

  2024cites this paper
• Recent advances in stem cell therapy: efficacy, ethics, safety concerns, and future directions focusing on neurodegenerative disorders – a review

  2024cites this paper
• Selenium nanoparticles decorated with polysaccharides from Sargassum fusiforme protects against 6-OHDA-induced neurotoxicity in PC12 cells and rat model of Parkinson's disease.

  2024cites this paper
• Dealing with the diagnosis of Parkinson’s disease and its implications for couple functioning in the early stage: An interpretative phenomenological analysis

  2024cites this paper
• A Study on the Effects of Repetitive Transcranial Magnetic Stimulation on EEG Microstate in Patients With Parkinson’s Disease

  2024cites this paper
• Association between serum IGF‑1 levels and non-motor symptoms in Parkinson’s disease

  2024cites this paper
• Does the Number of Turns during Sleep Have Utility in the Early Detection of Parkinson’s Disease and Its Related Disorders?

  2024cites this paper
• The relationship between physical function and psychological symptoms in Parkinson's disease: A systematic review and meta‐regression analysis

  2024cites this paper
• Urodynamic study and its correlation with cardiac meta‐iodobenzylguanidine (MIBG) in body‐first and brain‐first subtypes of Parkinson's disease

  2024cites this paper
• Perceptions of people with Parkinson’s on non-motor symptoms and functional ability

  2024cites this paper
• Functional neural networks stratify Parkinson's disease patients across the spectrum of cognitive impairment

  2024cites this paper
• Dopaminergic system and neurons: Role in multiple neurological diseases.

  2024cites this paper
• Investigation of the nonmotor symptoms in patients with STN-DBS therapy in comparison with those without STN-DBS

  2024cites this paper
• High-frequency multimodal training with a focus on Tai Chi in people with Parkinson’s disease: a pilot study

  2024cites this paper
• Oxidative Stress and Aging as Risk Factors for Alzheimer’s Disease and Parkinson’s Disease: The Role of the Antioxidant Melatonin

  2023cites this paper
• Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions

  2023cites this paper
• Biochemistry of exosomes and their theranostic potential in human diseases.

  2023cites this paper
• Paroxysmal Slow-Wave Events Are Uncommon in Parkinson’s Disease

  2023cites this paper
• Abnormal dynamic functional connectivity changes correlated with non-motor symptoms of Parkinson’s disease

  2023cites this paper
• Biogenesis, Composition and Potential Therapeutic Applications of Mesenchymal Stem Cells Derived Exosomes in Various Diseases

  2023cites this paper
• The interplay between neuroinflammatory pathways and Parkinson's disease.

  2023cites this paper
• Association of liver fibrosis with cognitive decline in Parkinson's disease.

  2023cites this paper
• Baseline prevalence and longitudinal assessment of autonomic dysfunction in early Parkinson’s disease

  2023cites this paper
• The effectiveness and safety of botulinum toxin injections for the treatment of sialorrhea with Parkinson's disease: a systematic review and meta-analysis

  2023cites this paper
• Nanowired delivery of antibodies to tau and neuronal nitric oxide synthase together with cerebrolysin attenuates traumatic brain injury induced exacerbation of brain pathology in Parkinson's disease.

  2023cites this paper
• Functional Neural Networks Stratify the Parkinson's Disease Patients Across the Spectrum of Cognitive Impairment

  2023cites this paper
• Recommendations on the Selection, Development, and Modification of Performance Outcome Assessments: A Good Practices Report of an ISPOR Task Force.

  2023cites this paper
• Restless Legs Syndrome and Impulse Control Disorders in Patients with Parkinson's Disease: An Intricate Association

  2023cites this paper
• Prevention of Parkinson's disease: from risk factors to early interventions.

  2023cites this paper
• Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study

  2023cites this paper
• Treatment of Parkinson's Disease: Current Treatments and Recent Therapeutic Developments.

  2023cites this paper
• Understanding the Molecular Aspects of Vitamins in Parkinson's Disease: Present-day Concepts and Perspectives.

  2023cites this paper
• Diffusion basis spectrum imaging detects pathological alterations in substantia nigra and white matter tracts with early-stage Parkinson’s disease

  2023cites this paper
• Parkinson's disease and oral health: A systematic review.

  2023cites this paper
• Clinicians’ view on the management of oral health in Parkinson’s disease patients: a qualitative study

  2023cites this paper
• Temporal and spatial variability of dynamic microstate brain network in early Parkinson’s disease

  2023cites this paper
• Clinical and Non-Clinical Cardiovascular Disease Associated Pathologies in Parkinson’s Disease

  2023cites this paper
• Synaptic dysfunction and dysregulation of extracellular matrix-related genes in dopaminergic neurons derived from Parkinson’s disease sporadic patients and with GBA1 mutations

  2023cites this paper
• Fenotipo motor y disautonomía cardiovascular de pacientes con enfermedad de Parkinson en la consulta de neurología de un hospital en Táchira (Venezuela)

  2022cites this paper
• Impact of Gastrointestinal Symptoms on Health-Related Quality of Life in an Australian Parkinson's Disease Cohort

  2022cites this paper
• Prevalence and characteristics of dry eye disease in Parkinson’s disease: a systematic review and meta-analysis

  2022cites this paper
• Parkinson’s Disease and the Gut Microbiome in Rural California

  2022cites this paper
• Orofacial pain and dysfunction in patients with Parkinson's disease: A scoping review

  2022cites this paper
• [Mechanisms of development of constipation in Parkinson's disease and therapeutic approaches].

  2022cites this paper
• Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis

  2022cites this paper
• Effects of repetitive transcranial magnetic stimulation on gait disorders and cognitive dysfunction in Parkinson's disease: A systematic review with meta‐analysis

  2022cites this paper
• Prevalence and Incidence of Nonmotor Symptoms in Individuals with and Without Parkinson's Disease

  2022cites this paper
• Modelling Behaviours of People Living with Neurodegenerative Conditions

  2022cites this paper
• Ability of Swept-source OCT and OCT-angiography to detect neuroretinal and vasculature changes in patients with Parkinson disease and essential tremor

  2022cites this paper
• Prevalence of lower urinary tract symptoms, urinary incontinence and retention in Parkinson's disease: A systematic review and meta-analysis

  2022influential citation
• Relationship between Apathy and Subjective Poor Night-time Sleep in de novo, Untreated Parkinson's Disease.

  2022cites this paper
• Parkinson’s disease, temporomandibular disorder pain and bruxism and its clinical consequences: a protocol of a single-centre observational outpatient study

  2022cites this paper
• Regulation of Oxidative Stress by Long Non-coding RNAs in Central Nervous System Disorders

  2022cites this paper
• Men working in dental hygiene

  2022cites this paper
• Age-Dependent Neuropsychiatric Symptoms in the NF-κB/c-Rel Knockout Mouse Model of Parkinson’s Disease

  2022cites this paper
• Role of dopamine and clinical heterogeneity in cognitive dysfunction in Parkinson's disease.

  2022cites this paper
• A cross-sectional study of knowledge and practices in the management of patients with Parkinson’s disease amongst public practice-based general practitioners and geriatricians

  2022cites this paper
• Interaction of an α-synuclein epitope with HLA-DRB1*15:01 triggers enteric features in mice reminiscent of prodromal Parkinson’s disease

  2022cites this paper
• Predictors of anxiety in Parkinson’s disease: results from a 3-year longitudinal cohort study

  2022cites this paper
• Brain network analysis between Parkinson's Disease and Health Control based on edge functional connectivity

  2022cites this paper
• Self-Reported Visual Complaints in People with Parkinson’s Disease: A Systematic Review

  2022cites this paper
• Investigating the Impact of Environment and Data Aggregation by Walking Bout Duration on Parkinson’s Disease Classification Using Machine Learning

  2022cites this paper
• Semantic Memory and Lexical Availability in Parkinson’s Disease: A Statistical Learning Study

  2021cites this paper
• Ramelteon ameliorated 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in neuronal cells in a mitochondrial-dependent pathway

  2021cites this paper
• “I’m Never Going to Be in Phantom of the Opera”: Relational and Emotional Wellbeing of Parkinson’s Carers and Their Partners in and Beyond Dancing

  2021cites this paper
• Nonmotor symptoms and quality of life in Parkinson’s disease with different motor subtypes

  2021cites this paper
• Case-control study of hypertension and Parkinson’s disease

  2021cites this paper
• Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management

  2021cites this paper
• Interactions between the microbiota and enteric nervous system during gut-brain disorders.

  2021cites this paper
• Hearing Loss in Neurological Disorders

  2021cites this paper